There were also reports that the overexpression of IGF2BP3 was closely related to poor prognosis in endometrial carcinoma (Fadare et al., 2013), oral squamous cell carcinoma (Lin et al., 2011), colorectal cancer (Shantha Kumara et al., 2015), ovarian cancer (Hsu et al., 2015), and lung adenocarcinoma (Guo et al., 2021). This evidence concerns the gene IGF2BP3 and ovarian carcinoma.